India has the potential to increase exports of organic products up to Rs 20,000 crore in the next three years, Commerce and ...

INR:2805. betfair market load The 2019 final announcement of the "National Pharmaceutical Excipient Standards Preparation Guidelines" in line with internation ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

In a pursuit to make quality healthcare more affordable, India has opened over 14,000 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) as of October 21. These outlets provide generic medicines at ...

China and India agreed on Wednesday to work on easing their long-running border dispute, as the two Asian giants resumed a formal high-level dialogue for the first time in five years. Chinese ...

India's path to the 2025 World Test Championship Final remains open despite a draw against Australia. Two wins in the remaining Border-Gavaskar Trophy matches would guarantee their spot.

The two joined hands after the ninth wicket fell when India still needed 33 runs to avoid batting again, in reply to Australia's 445. The visitors trail Aussies by 185 runs, but they wouldn't mind ...

Rain had the last word at the Gabba, as was widely expected, but only after Australia and India conjured up the most intriguing of what-ifs in the 22 overs that were possible on the fifth day of ...

India’s Nitish Kumar Reddy and Ravindra Jadeja run off the ground due to a rain delay on day four of the third Test against Australia at The Gabba in Brisbane.(AFP) Follow-on rules in cricket ...

affordable medications," Granules Ltd Chairman & Managing Director Krishna Prasad Chigurupati said. Shares of Granules India were trading 0.74 per cent up at Rs 588.65 apiece on BSE.

Drug firm Granules India on Tuesday said its subsidiary has received approval from the US health regulator for a generic medication used to treat attention-deficit hyperactivity disorder. Granules ...

Drug firm Granules India announced on Tuesday that its subsidiary, Granules Pharmaceuticals Inc, has secured approval from the US health regulator to produce a generic medication for treating ...